Taxane-sensitivity of ovarian carcinomas previously treated with paclitaxel and carboplatin.

about

Taxane-sensitivity of ovarian carcinomas previously treated with paclitaxel and carboplatin.

Item

http://www.wikidata.org/entity/Q43409591

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Taxane-sensitivity of ovarian ...... th paclitaxel and carboplatin.

@en

Taxane-sensitivity of ovarian ...... th paclitaxel and carboplatin.

@nl

type

Item

label

Taxane-sensitivity of ovarian ...... th paclitaxel and carboplatin.

@en

Taxane-sensitivity of ovarian ...... th paclitaxel and carboplatin.

@nl

prefLabel

Taxane-sensitivity of ovarian ...... th paclitaxel and carboplatin.

@en

Taxane-sensitivity of ovarian ...... th paclitaxel and carboplatin.

@nl

P1476

Taxane-sensitivity of ovarian ...... th paclitaxel and carboplatin.

@en

P2093

Eiji Kobayashi

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Yoshino

http://www.w3.org/2001/XMLSchema#string

Masami Fujita

http://www.w3.org/2001/XMLSchema#string

Tadashi Kimura

http://www.w3.org/2001/XMLSchema#string

Takayuki Enomoto

http://www.w3.org/2001/XMLSchema#string

Tateki Tsutsui

http://www.w3.org/2001/XMLSchema#string

Toshihiro Kimura

http://www.w3.org/2001/XMLSchema#string

Yutaka Ueda

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results.

Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.

Phase II study of pegylated liposomal doxorubicin and carboplatin in patients with platinum-sensitive and partially platinum-sensitive metastatic ovarian cancer.

Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.

Part II: chemotherapy for epithelial ovarian cancer-treatment of recurrent disease.

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.

A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group study.

Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer.

Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse.

P2888

s00280-013-2138-5

P304

1411-1416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-013-2138-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shinya Matsuzaki

P577

2013-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1020854128

http://www.w3.org/2001/XMLSchema#string

P698

23515753

http://www.w3.org/2001/XMLSchema#string